245 related articles for article (PubMed ID: 10952081)
1. Five decades of antihypertensive treatment: the unresolved issues.
Julius S
J Hypertens Suppl; 2000 Jul; 18(3):S3-7. PubMed ID: 10952081
[TBL] [Abstract][Full Text] [Related]
2. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
3. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
Oparil S; Bakir SE
Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856
[TBL] [Abstract][Full Text] [Related]
4. The future of antihypertensive treatment.
Israili ZH; Hernández-Hernández R; Valasco M
Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
[TBL] [Abstract][Full Text] [Related]
5. [Are all antihypertensive drugs renoprotective?].
Wolf S; Risler T
Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950
[TBL] [Abstract][Full Text] [Related]
6. [Drugs and arterial stiffness in hypertensive patients].
Laurent S
Drugs; 2003; 63 Spec No 1():1-8. PubMed ID: 12708878
[TBL] [Abstract][Full Text] [Related]
7. Effects of antihypertensive drug treatment on the risk of dementia and cognitive impairment.
Poon IO
Pharmacotherapy; 2008 Mar; 28(3):366-75. PubMed ID: 18294116
[TBL] [Abstract][Full Text] [Related]
8. Redefining efficacy of antihypertensive therapies beyond blood pressure reduction--the role of angiotensin II antagonists.
Conlin PR
Int J Clin Pract; 2005 Feb; 59(2):214-24. PubMed ID: 15854200
[TBL] [Abstract][Full Text] [Related]
9. Blood pressure lowering, not vascular mechanism of action, is the primary determinant of clinical outcome.
Leenen FH
Can J Cardiol; 2004 Aug; 20 Suppl B():77B-82B. PubMed ID: 15309209
[TBL] [Abstract][Full Text] [Related]
10. [Cerebrovascular sequelae of hypertension].
Schrader J; Lüders S; Diener HC
Herz; 2003 Dec; 28(8):707-16. PubMed ID: 14689105
[TBL] [Abstract][Full Text] [Related]
11. Discordant effects of beta-blockade on central aortic systolic and brachial systolic blood pressure: considerations beyond the cuff.
Epstein BJ; Anderson S
Pharmacotherapy; 2007 Sep; 27(9):1322-33. PubMed ID: 17723086
[TBL] [Abstract][Full Text] [Related]
12. Treatment of essential hypertension with calcium channel blockers: what is the place of lercanidipine?
Burnier M; Pruijm M; Wuerzner G
Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):981-7. PubMed ID: 19619074
[TBL] [Abstract][Full Text] [Related]
13. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
[TBL] [Abstract][Full Text] [Related]
14. Treatment of hypertension in chronic kidney disease.
Toto RD
Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
[TBL] [Abstract][Full Text] [Related]
15. Antihypertensive therapy: new strategies beyond blood pressure control.
Stumpe KO
J Cardiovasc Pharmacol; 1992; 20 Suppl 6():S1-4. PubMed ID: 1283182
[TBL] [Abstract][Full Text] [Related]
16. Use of antihypertensive drugs and trends in blood pressure in the elderly.
Glynn RJ; Brock DB; Harris T; Havlik RJ; Chrischilles EA; Ostfeld AM; Taylor JO; Hennekens CH
Arch Intern Med; 1995 Sep; 155(17):1855-60. PubMed ID: 7677551
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin receptor blockade in the challenging era of systolic hypertension.
Stergiou GS
J Hum Hypertens; 2004 Dec; 18(12):837-47. PubMed ID: 15318161
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
Palmieri V; Devereux RB
Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
[TBL] [Abstract][Full Text] [Related]
19. Eprosartan provides safe and effective long-term maintenance of blood pressure control in patients with mild to moderate essential hypertension.
Levine B
Curr Med Res Opin; 2001; 17(1):8-17. PubMed ID: 11464450
[TBL] [Abstract][Full Text] [Related]
20. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Rahman M; Pressel S; Davis BR; Nwachuku C; Wright JT; Whelton PK; Barzilay J; Batuman V; Eckfeldt JH; Farber M; Henriquez M; Kopyt N; Louis GT; Saklayen M; Stanford C; Walworth C; Ward H; Wiegmann T
Arch Intern Med; 2005 Apr; 165(8):936-46. PubMed ID: 15851647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]